Sire Bioscience Inc Cash Flow Statement

SIRE C$0.29 -0.0 -6.5%

26/02/21

Highly Speculative, Micro Cap, Style Neutral

Market Cap £6.93m

Enterprise Value £9.95m

Revenue £277k

Quality

Value

Momentum

StockRank™

To unlock Sire Bioscience Inc's cashflow statement please upgrade your membership.

	2016	2017	2018	2019	2019	2020
Period End:	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2019-09-30	2020-09-30
Period Length:	12M	12M	12M	12M	6M	12M
Currency:	CAD	CAD	CAD	CAD	CAD	CAD

Net Income/Starting Line

Depreciation/Depletion
Non-Cash Items
Unusual Items
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Inventories
Prepaid Expenses
Payable/Accrued
Other Operating Cashflow
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Other Investing Cash Flow Items, Total
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.